Meanwhile, the amount of distressed debt is small and is concentrated in the low single B/CCC part of the market, so we don’t expect it to become a systemic concern. For the
Weaker Growth Means Lower Rates While anything is possible at this stage, there could be opportunities to avert the worst-case outcomes. Tariff proposals may not be fully enacted, as targeted countries may
Natural Language Processing Changes the Game Clearly, if asset managers could uncover ESG-related controversies faster than their peers, they’d have an investment edge. But that’s easier said than done. Manually sifting through
Data shows that markets rise regardless of who sits in the Oval Office, but a divided Congress has been best for equities performance (YCharts) Trump plans to lower corporate tax by 6%,
According to Cervicorn Consulting, the India semiconductor market size is anticipated to exceed around USD 105.34 billion by 2033 and is expanding at a CAGR of 20.70% from 2024 to 2033. The
High-yield investors put off by today’s narrow spreads could be missing out. With high-yield credit spreads hovering near all-time lows, some investors may be tempted to sit on the sidelines until spreads
Global markets will face powerful disruptive forces next year. How can investors prepare in fixed-income, equity and alternative investment strategies? Investors are grappling with a multidimensional set of challenges as we turn
Ever thought about optimizing your financial management and investments while effectively managing your budget? With the rapid advancements in technology, top apps for wealth management have become essential tools for individuals aiming
Direct lending: Favorable setup for compelling risk-adjusted dynamics in 2025 Ron Kantowitz The US economy continued to demonstrate strength in 2024, although core PCE, the Fed’s preferred measure of inflation, has proven more
Emerging-market (EM) equities are off to a strong start in 2025, up 4.5% through March 14 in US-dollar terms. But investors could be excused for being wary. After all, emerging markets have
With the cell and gene therapies (CGTs) sector facing multiple challenges even as it celebrates successes, there was plenty for experts to discuss at the 2025 Cell & Gene Therapy Summit. Hosted